Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Shares Issued: 2014-2024

Historic Shares Issued for Editas Medicine (EDIT) over the last 11 years, with Dec 2024 value amounting to $590,000.

  • Editas Medicine's Shares Issued was N/A to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year change of. This contributed to the annual value of $590,000 for FY2024, which is 99.50% down from last year.
  • Latest data reveals that Editas Medicine reported Shares Issued of $590,000 as of FY2024, which was down 99.50% from $117.1 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Shares Issued ranged from a high of $249.5 million in FY2021 and a low of $590,000 during FY2024.
  • Moreover, its 3-year median value for Shares Issued was $979,000 (2022), whereas its average is $39.5 million.
  • Per our database at Business Quant, Editas Medicine's Shares Issued tumbled by 99.61% in 2022 and then soared by 11,859.04% in 2023.
  • Yearly analysis of 5 years shows Editas Medicine's Shares Issued stood at $203.7 million in 2020, then rose by 22.45% to $249.5 million in 2021, then slumped by 99.61% to $979,000 in 2022, then spiked by 11,859.04% to $117.1 million in 2023, then plummeted by 99.50% to $590,000 in 2024.